Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

14,474 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    FDA Determines That Tessalon (Benzonatate) Capsules And Other Drug Products Were Not Withdrawn From Sale For Reasons Of Safety Or Effectiveness

    In the July 20, 2015, Federal Register, FDA announced its determination that the drug products listed in the notice were not withdrawn from sale for reasons of safety or effectiveness.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Develops Online Learning Module To Help Ensure Proper Labeling Of Seafood Products

    The module provides an overview of federal labeling requirements, tips for identifying mislabeled seafood, and a list of governing laws, regulations, and guidance documents.
    United StatesFood, Drugs, Healthcare, Life Sciences
Jones Day
Jones Day
  • Article

    FDA Establishes Public Docket For Use Of The Inactive Ingredient Database

    In the August 20, 2015, Federal Register, FDA announced the establishment of a public docket to receive comments from interested parties on enhancing the utility and usability of the Inactive Ingredient Database.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Extends Closing Date Of Intent To Participate In Consultation Of Reauthorization Of The Generic Drug User Fee Amendments Of 2012

    The FDCA requires FDA to consult with a range of stakeholders in developing recommendations for the next GDUFA program.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Extends Comment Period For CMC Guidance Document

    In the October 6, 2015, Federal Register, FDA announced it is reopening the comment period for the "Established Conditions: Reportable Chemistry, Manufacturing, and Controls ("CMC") Changes...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Extends Comment Period For Inorganic Arsenic In Rice Cereals For Infants

    In the June 30, 2016, Federal Register, the FDA announced the extension of the comment period for a draft guidance titled "Inorganic Arsenic in Rice Cereals for Infants: Action Level".
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Extends Comment Period For MMA Proposed Rule On Approval Of ANDAs

    This provision of the MMA governs the approval of 505(b)(2) applications and ANDAs.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Extends Comment Period For Proposed Rule On Electronic Distribution Of Prescribing Information For Drugs And Biologics

    In the March 9, 2015, Federal Register, FDA announced it is extending the comment period for the proposed rule, announced December 18, 2014, to amend labeling regulations for human prescription drugs...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Extends Comment Period For Rare Pediatric Disease Priority Review Vouchers

    In the December 24, 2014, Federal Register, FDA announced that it has extended the comment period regarding the Agency's implementation of the Rare Pediatric Disease Priority Review Vouchers Program.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Extends Comment Period For Updates To The Redbook

    FDA is seeking to expand the scope of the Redbook to emphasize principles of safety and risk assessment shared across different regulatory contexts for foods and cosmetics...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Extends Comment Period On Proposed Rule To Revise Nutrition Labels

    The consumer studies pertained to proposed changes to the Nutrition Facts label formats.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Extends Comment Period On Sanitary Transportation Proposed Rule

    In the May 23 Federal Register, FDA announced that it will extend the comment period on the sanitary transportation proposed rule by 60 days.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Extends Comment Period On Use Of Term "Natural" On Food Labeling

    In the December 28, 2015, Federal Register, FDA announced the extension of the comment period for a docket to receive comments on use of the term "natural" on labeling of human food products...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Extends Compliance Date For Final Rule On Menu Disclosures

    In the July 10, 2015, Federal Register, FDA announced a one-year extension of the compliance date for the final rule on Menu Labeling...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Extends Nomination Period For List Of Bulk Drugs Used By Outsourcing Facilities

    In the July 20, 2015, Federal Register, FDA announced it was extending the nomination period for bulk drug substances that may be used by facilities registered as outsourcing facilities to compound animal drugs from bulk substances.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Extends Nomination Period For Nonvoting Member Of CFSAN Advisory Committee

    FDA announced an extension of its call for nominations and for industry organizations to participate in the selection of nonvoting industry representatives to serve on the Food Advisory Committee for CFSAN.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Files Color Additive Petition For Safe Use Of Spirulina Extract

    FDA announced the filing of a petition, submitted by McCormick & Company, Inc., that proposes that the color additive regulations be amended to provide for the safe use of spirulina extract to color shell eggs.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Files Minutes Of Closed Advisory Committee Minutes With Library Of Congress

    In the December 30, 2014, Federal Register, FDA announced that the Agency has filed with the Library of Congress the annual reports of FDA advisory committees that held closed meetings during fiscal year 2014.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Finalizes Board Member Conflict Of Interest Policies

    FDA finalized policies for the public disclosure of financial ties of advisory board members whose votes prove critical to the approval of new drugs.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Finalizes Rule And Guidances On Record Access Requirements

    The FDA released two Guidances and finalized the rule implementing its expanded authority to access records of food manufacturers.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Showing 581–600 of 14474 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics